Use of donepezil for the treatment of mild - moderate Alzheimer's disease: an audit of the assessment and treatment of patients in routine clinical practice
- 18 October 2000
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 15 (10) , 887-891
- https://doi.org/10.1002/1099-1166(200010)15:10<887::aid-gps212>3.0.co;2-m
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial Commentary: Another piece of the Alzheimer's jigsawBMJ, 1999
- ▼Donepezil updateDrug and Therapeutics Bulletin, 1998
- Donepezil Improves Cognition and Global Function in Alzheimer DiseaseA 15-Week, Double-blind, Placebo-Controlled StudyArchives of internal medicine (1960), 1998
- A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's diseaseNeurology, 1998
- Measuring the effects of anti-dementia drugs in patients with Alzheimer's diseaseHuman Psychopharmacology: Clinical and Experimental, 1997
- French recommendations for clinical drug trials in cognitive disorders of the elderlyInternational Journal of Geriatric Psychiatry, 1994
- Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State ExaminationAmerican Journal of Psychiatry, 1991
- The Barthel ADL Index: A standard measure of physical disability?International Disability Studies, 1988
- EVALUATION OF A MENTAL TEST SCORE FOR ASSESSMENT OF MENTAL IMPAIRMENT IN THE ELDERLYAge and Ageing, 1972